AKT1 and carcinoma: Regarding the carcinoma phenotype, we previously found that coadministration of c-myc and AKT plasmids results in cervicovaginal carcinoma when administered with HPV16 E6/E7-luciferase and SB100 in the cervicovaginal track (19).